| Monday, June 23, 2025 Abstract Session 18 – CRS – Biologics 1 ROOM 13 (G15) | Level +1 11:35h – 12:50h ABSTRACTS |
| Chair: Helga Kraxner |
| 4103 – Sequence Of Improvements in Objective and Patient-Reported Outcomes with Dupilumab Treatment in Patients with CRSwNP |
| De Corso Eugenio |
| 4189 – Monitoring microvascular regression using Narrow Band Imaging (NBI) – optical biopsy – in the biological therapy of chronic rhinosinusitis with nasal polyposis (CRSwNP) |
| Bódi Anna |
| 3793 – Stapokibart improves outcomes in patients with CRSwNP regardless of comorbid allergic rhinitis |
| Wu Di |
| 3795 – Stapokibart efficacy in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma |
| Shen Shen |
| 3796 – Stapokibart demonstrates favorable efficacy regardless of sinus surgery history in chronic rhinosinusitis and nasal polyps: a post hoc analysis of phase 3 results |
| Deng Yuzhoujia |
| 4192 – Improving quality of life in chronic rhinosinusitis with nasal polyps: the impact of dupilumab and mepolizumab |
| Teixeira Marques Francisco |
| 4202 – Assessment of the sense of smell in patients with chronic rhinosinusitis with nasal polyps one year into treatment with mepolizumab |
| Schayman Dopico Waleska |
| 4223 – Changes in olfactory ability over time in CRSwNP patients treated with dupilumab. Association with the number of sinus surgeries |
| Kraxner Helga |
